No PHI in controlled pilot
Controlled pilot access is limited to public, synthetic, or de-identified cases unless a separate security and contract review explicitly allows otherwise.
Governed pilot access with strict clinical boundaries.
Tynixa supports review-ready genomic workflows under human review. It does not provide autonomous final diagnosis, final ACMG classification, treatment recommendation, or clinical release.
Human review required
Outputs are draft-only and designed for qualified human review and sign-off.
Payment boundary
Payment activates governed pilot workspace access only. It does not unlock final clinical features.
Blocked during controlled pilot
Final diagnosis, final ACMG classification, treatment recommendation, clinical release, autonomous finalization, raw patient identifiers, and uncontrolled PHI workflows remain blocked.
Controlled Pilot Details